Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Toronto Stock Exchange  >  Profound Medical Corp.    PRN   CA74319B5027

PROFOUND MEDICAL CORP.

(PRN)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Toronto Stock Exchange
09/21/2020 09/22/2020 09/23/2020 09/24/2020 09/25/2020 Date
22.81(c) 23.51(c) 21.86(c) 21.93(c) 22.11(c) Last
56 247 67 302 83 526 106 064 167 202 Volume
+0.26% +3.07% -7.02% +0.32% +0.82% Change
More quotes
Financials
Sales 2020 8,10 M 6,05 M 6,05 M
Net income 2020 -24,0 M -17,9 M -17,9 M
Net Debt 2020 - - -
P/E ratio 2020 -16,5x
Yield 2020 -
Sales 2021 26,1 M 19,5 M 19,5 M
Net income 2021 -17,4 M -13,0 M -13,0 M
Net Debt 2021 - - -
P/E ratio 2021 -23,8x
Yield 2021 -
Capitalization 428 M 319 M 319 M
Capi. / Sales 2020 52,8x
Capi. / Sales 2021 16,4x
Nbr of Employees 75
Free-Float 98,0%
More Financials
Company
Profound Medical Corp. is a commercial-stage medical device company. focused on customizable, incision-free therapies which combine real-time magnetic resonance imaging (MRI), thermal ultrasound and closed-loop temperature feedback control for the radiation-free ablation of diseased tissue. The Company’s products include TULSA-PRO System and SONALLEVE. The TULSA-PRO is used to ablate benign or malignant prostate... 
More about the company
Notations Surperformance© of Profound Medical Corp.
Trading Rating : Investor Rating :
More Ratings
All news about PROFOUND MEDICAL CORP.
09/09Profound Medical to Present at the Cantor Virtual Global Healthcare Conferenc..
GL
08/10Profound Medical Present at the Canaccord Genuity 40th Annual Growth Conferen..
GL
08/06Profound Medical Announces Second Quarter 2020 Financial Results
GL
07/22Profound Medical to Release Second Quarter 2020 Financial Results on August 6..
GL
07/21Profound Medical Announces Closing of Offering
GL
07/15Profound Medical Announces Pricing of Offering of Common Shares
GL
07/15Profound Medical Announces Proposed Offering of Common Shares
GL
05/20Profound Medical Annual and Special Meeting of Shareholders Voting Results
GL
05/07Profound Medical Announces First Quarter 2020 Financial Results
GL
04/16Profound Medical to Release First Quarter 2020 Financial Results on May 7 &nd..
GL
03/03Profound Medical Announces Fourth Quarter and Full Year 2019 Financial Result..
GL
02/26Profound Medical Participate in March Investor Healthcare Conferences
GL
01/22PROFOUND MEDICAL : IIROC Trade Resumption - PRN
AQ
01/22PROFOUND MEDICAL : IIROC Trading Halt - PRN
AQ
2019PROFOUND MEDICAL CORP. : Opens the Market
AQ
More news
News in other languages on PROFOUND MEDICAL CORP.

- No features available -

More news
Chart PROFOUND MEDICAL CORP.
Duration : Period :
Profound Medical Corp. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PROFOUND MEDICAL CORP.
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 8
Average target price 28,23 CAD
Last Close Price 22,11 CAD
Spread / Highest target 94,5%
Spread / Average Target 27,7%
Spread / Lowest Target -26,7%
EPS Revisions
Managers
NameTitle
Arun S. Menawat Chairman & Chief Executive Officer
Aaron Davidson CFO & Senior VP-Corporate Development
Goldy Singh Vice President-Clinical & Regulatory Affairs
Mathieu Burtnyk Vice President-Clinical Affairs
Jean-François Pariseau Independent Director
Sector and Competitors